[Results of the clinical use of cefminox in the field of obstetrics and gynecology].
Cefminox (CMNX, MT-141) was used in the treatment of obstetrical and gynecological infections with following results. In the treatment of a total of 8 cases including 4 cases of intrauterine infections, 2 cases of pyosalpinx and 2 cases of pelvioperitonitis, clinical results obtained were rated as excellent in 4 cases (50%) and good in 2 cases (25%). When good and excellent results were combined as representing effectiveness, the effective rate was 75% (6/8 cases). The 2 cases, which gave poor results, were under treatment for ovarian carcinoma. CMNX was found effective for intrauterine infections (postpartal) and pyosalpinx, especially those caused by E. coli. None of the cases experienced side effects.
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002513:Cephamycins / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D014591:Uterine Diseases / Q000188:drug therapy*
D002513:Cephamycins; C046079:cefminox